29 results on '"Baratta, F."'
Search Results
2. OC 10.4 Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors Reduce Platelet Nets Release Driver Thrombosis in Familial Hypercholesterolemia
3. PROC3 derived scores for liver fibrosis predict cardiovascular events in NAFLD patients
4. Role of NAFLD-associated genetic variants on renal function in patients with nonalcoholic fatty liver disease
5. Lipid profile, oxidative stress and platelets activation after albumin infusion in congenital analbuminemia
6. Impaired HDL cholesterol efflux capacity in subjects with metabolically- but not genetically- driven non-alcoholic fatty liver disease (NAFLD)
7. Liver fibrosis and cardiovascular events in non-alcoholic fatty liver disease. The prospective cohort plinio study
8. Correlation between Dutch lipid score and genetic diagnosis of FH in pediatric patients
9. Lysosomal Acid Lipase Activity And Hepatic Fibrosis In Non-Alcoholic Fatty Liver Disease
10. Enhanced urinary excretion of thromboxane B2 in non-alcoholic fatty liver disease. Implication for antiplatelet treatment
11. Increased gut permeability is associated with oxidative stress in patients with NAFLD
12. Effects of dark chocolate on endothelial function in patients with non-alcoholic steatohepatitis
13. Progressive reduction of blood lysosomal acid lipase activity according to stage of adult chronic liver disease and altered enzymatic cellular distribution in cirrhosis
14. Low-grade endotoxemia, gut permeability and platelet activation in patients with impaired fasting glucose
15. Under-prescription of statins in patients with non-alcoholic fatty liver disease
16. Targeted sequencing of APOC3, GCKR, LIPA, PPP1R3b, NCAN, LYPLAL1 and TM6SF2 genes in patients with nonalcoholic fatty liver disease (NAFLD)
17. Visceral fat evaluated by ultrasound is associated with insulin resistance and liver damage in patients with non-alcoholic fatty liver disease
18. Adherence to Mediterranean Diet and non-alcoholic fatty liver disease: Impact on metabolic profile
19. Spleen Dimensions Evaluated by Ultrasound are Inversely Associated with Lysosomal Acid Lipase Activity in Patients with Non-Alcoholic Fatty Liver Disease
20. P1049 : Lysosomal Acid Lipase activity in patients with non-alcoholic fatty liver disease
21. Non-alcoholic fatty liver disease, metabolic syndrome and patatin-like phospholipase domain-containing protein3 gene variants
22. P825 NON-ALCOHOLIC FATTY LIVER DISEASE IS ASSOCIATED WITH REDUCED SERUM CHOLESTEROL-ADJUSTED VITAMIN E LEVELS
23. P812 NOX2-GENERATED OXIDATIVE STRESS IS INCREASED IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE INDEPENDENTLY FROM METABOLIC SYNDROME
24. P848 SERUM CYTOKERATIN-18 IS ASSOCIATED WITH OXIDATIVE STRESS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
25. NOX2-generated oxidative stress is increased in patients with non-alcoholic fatty liver disease independently from metabolic syndrome
26. 1361 LACK OF ASSOCIATION BETWEEN METABOLIC SYNDROME AND NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH PNPLA3 M148M GENE VARIANT
27. F-21 PNPLA3 I148M gene variant is not associated with metabolic syndrome and cardiometabolic risk in non-alcoholic fatty liver disease
28. Development of O/W nanoemulsions for ophthalmic administration of timolol
29. Under-prescription of statins in patients with non-alcoholic fatty liver disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.